MedTrace Logo

Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias

NCT03769207 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2020-10-20

Study results available
· View outcomes & findings →

Summary

This post-marketing study is conducted to characterize the ability of Apple Watch rhythm analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical evaluation among users who contact AppleCare.

Conditions

Interventions

DEVICE

Ambulatory ECG

Eligible participants are asked to wear the ambulatory ECG monitor

Sponsors & Collaborators

  • Apple Inc.

    lead INDUSTRY

Principal Investigators

  • Marco V Perez, MD · Stanford University

  • Minang (Mintu) Turakhia, MD, MAS · Stanford University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-08
Primary Completion
2019-07-05
Completion
2019-08-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03769207 on ClinicalTrials.gov